ORCID as entered in ROS

Select Publications
2001, 'Co-morbidity between alcohol, tobacco and cannabis use: Reply', ADDICTION, 96, pp. 1862 - 1863, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172551200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'Co-morbidity between alcohol, tobacco and cannabis use: Reply to David Fergusson [8]', Addiction, 96, pp. 1862 - 1863
,2001, 'Allowing the medical use of cannabis', Medical Journal of Australia, 175, pp. 39 - 40, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143512.x
,2001, 'WHO/ISBRA study on state and trait markers in alcoholism', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 25, pp. 99S - 103S, http://dx.doi.org/10.1097/00000374-200105051-00018
,2001, 'Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis', Addiction, pp. 1603 - 1614
,2001, 'Ambulance calls to suspected overdoses: NSW patterns July 1997 to June 1999', Australian and New Zealand Journal of Public Health, pp. 447 - 450
,2001, 'Ketamine and GHB: New trends in club drug use?', Journal of Substance Use, pp. 11 - 15
,2001, 'The association between psychosis and problematical drug use among Australian adults: Findings from the National Survey of Mental Health and Well-Being', Psychological Medicine, pp. 659 - 668
,2001, 'The relationship between cannabis use and other substance use in the general population', Drug and Alcohol Dependence, pp. 319 - 327
,2001, 'The relationship between cannabis use, depression and anxiety among Australian adults: Findings from the National Survey of Mental Health and Well-Being', Social Psychiatry and Psychiatric Epidemiology, pp. 219 - 227
,2001, 'The validity of an Australian modification of the AUDIT questionnaire', Drug and Alcohol Review, 20, pp. 143 - 154
,2001, 'The validity of an Australian modification of the AUDIT questionnaire', Drug and Alcohol Review, 20, pp. 143 - 154, http://dx.doi.org/10.1080/09595230124592
,2001, 'WHO/ISBRA study on state and trait markers in alcoholism', Alcoholism : Clinical and Experimental Research, pp. 99 - 103
,2000, 'Cohort trends in youth suicide in Australia 1964-1997', Australian and New Zealand Journal of Psychiatry, 34, pp. 408 - 412, http://dx.doi.org/10.1046/j.1440-1614.2000.00740.x
,2000, 'Cohort trends in youth suicide in Australia 1964-1997', Australian and New Zealand Journal of Psychiatry, 34, pp. 408 - 412, http://dx.doi.org/10.1046/j.1440-1614.2000.00740.x
,2000, 'Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and wellbeing', Australian and New Zealand Journal of Psychiatry, pp. 206 - 213
,2000, 'Cannabis use and psychosis: A review of clinical and epidemiological evidence', Australian and New Zealand Journal of Psychiatry, pp. 26 - 34
,2000, 'Interventions for people with alcohol use disorders and an intellectual disability: A review of the literature', Journal of Intellectual and Developmental Disability, pp. 135 - 146
,2000, 'Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995', Drug and Alcohol Dependence, pp. 247 - 254
,1999, 'Opioid overdose mortality in Australia, 1964-1997: Birth-cohort trends', Medical Journal of Australia, 171, pp. 34 - 37, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123495.x
,1999, 'Opioid overdose mortality in Australia, 1964-1997', Medical Journal of Australia, 171, pp. 34 - 37
,1999, 'The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being', Addiction, pp. 1541 - 1550
,1998, 'The decline in alcohol disorders with age: Causes and implications', Australian Journal on Ageing, 17, pp. 158 - 159
,'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International journal of population data science, 7
,'The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Well-Being',
,2024, '181 Age-related risk of serious fall events associated with opioid analgesic use', in Abstracts, BMJ Publishing Group Ltd, pp. A35.1 - A35, presented at 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) abstracts, http://dx.doi.org/10.1136/injuryprev-2024-safety.83
,2023, 'Family and peer-related mediators of the relationship between parental supply of alcohol and subsequent alcohol-related harms among Australian adolescents', in ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, WILEY, WA, Bellevue, pp. 114 - 115, presented at 46th Annual Scientific Meeting of the Research-Society-on-Alcohol (RSA), WA, Bellevue, 24 June 2023 - 28 June 2023
,2023, 'Agreement between self-reported illicit drug use and biological samples: A systematic review and meta-analysis', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S41 - S42
,2023, 'Association of opioid analgesics, benzodiazepines, gabapentinoids and opioid agonist treatment with mortality among individuals with opioid dependence', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S40 - S41
,2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S65 - S66
,2023, 'Global patterns of drug use among people who inject drugs', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S183 - S184
,2023, 'National trends in the Australian opioid agonist treatment program, 2013 to 2022', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S40 - S40
,2023, 'Ninety-six week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a singlearm trial', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S72 - S73
,2023, 'Prevalence of substance use disorders among individuals with opioid use disorder: A systematic review and meta-analysis', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S162 - S162
,2023, 'The risk of fatal opioid overdose associated with the concurrent use of opioid analgesics and psychotropic medicines: A retrospective population-based cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 589 - 590
,2022, 'How can a new formulation reduce stigma linked to opiate agonist treatment?: Place, time and things in the experience of extended-release buprenorphine depot', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S137 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Options: Exploring patients' experiences with depot buprenorphine and their motivations to discontinue', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S43 - S43, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'The prevalence of gambling and gambling-related harm: A systematic review and meta-analysis of the evidence', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S48 - S48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084401349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Trajectories of parental and peer supply of alcohol in adolescence and associations with later alcohol consumption and harms: A prospective cohort study', in Drug and Alcohol Dependence, WILEY, pp. S43 - S43, http://dx.doi.org/10.1016/j.drugalcdep.2022.109533
,2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', in International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2022.103706
,2022, 'Executive Function and Impulsivity Predict Distinct Genetic Variance in Externalizing, Internalizing, Thought Disorders, and Cognition: A Genomic Structure Equation Modeling Investigation', in BEHAVIOR GENETICS, SPRINGER, CA, Los Angeles, pp. 367 - 368, presented at 52nd Annual Meeting of the Behavior-Genetics-Association (BGA), CA, Los Angeles, 22 June 2022 - 25 June 2022
,2022, 'Disproportionate HIV burden among key populations in sub-Saharan Africa: national estimates of population size, HIV prevalence, and ART coverage', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, pp. 127 - 129
,2021, '"WE'VE HAD A CIRCUIT BREAKER FOR AN OLD DOGMA OF MORE THAN 20 YEARS": CHANGES TO OPIOID AGONIST TREATMENT SERVICES DURING COVID-19, THE CHOICE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'CHANGES IN ALCOHOL USE AND MENTAL HEALTH AMONG YOUNG AUSTRALIAN ADULTS DURING THE COVID-19 PANDEMIC: A PROSPECTIVE COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S56 - S57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'DRUG-INDUCED DEATHS AND DRUG-RELATED HOSPITALISATIONS BY REMOTENESS AREA OF USUAL RESIDENCE IN AUSTRALIA, 2018-2019', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S102 - S103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200252&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'OPIOID OVERDOSE AND NALOXONE ACCESS AMONG PEOPLE WHO RECENTLY USED OPIOIDS OR RECEIVED OPIOID AGONIST TREATMENT IN AUSTRALIA: THE ETHOS ENGAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S59 - S60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200149&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'THE EFFECT OF PERSON, TREATMENT AND PRESCRIBER CHARACTERISTICS ON RETENTION IN OPIOID AGONIST TREATMENT: A 15-YEAR RETROSPECTIVE COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S46 - S47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Adolescent Alcohol Use Trajectories: A Prospective Study of Risk Factors and Adulthood AUD Outcomes', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, pp. 261 - 261, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000983532000003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'POPPY II cohort profile- a population-based linked cohort examining the course and outcomes of prescription opioid use in NSW, Australia, 2003-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 300 - 301, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300611&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,